(Reuters) -Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment ...

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms ...

If glaucoma is caught early, monitored by a doctor and properly treated, it’s possible to stall the progression of the ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

Additional risk factors include contact lens wear, previous eye surgery, residence in dry climates, excessive screen time, ...

A new randomized controlled trial reveals that topical timolol significantly improves the appearance of post-mammoplasty ...